Alert icon

To align with industry best practices for security and data integrity, Project Data Sphere is requiring users to upgrade their browsers to one that supports encryption protocol TLS 1.2 by December 15, 2017. On that date, Project Data Sphere will disable support of browsers that permit SSL 3.0/TLS 1.0. To prevent any disruption to your access to Project Data Sphere, you must take action.
This browser was not recognized and may not be compatible with TLS 1.2 or higher. Please check with the browser's developer to confirm.
To view information about this, please visit the FAQ. If you have any further questions, please contact us.

Back to the List
Type(s) of Cancer
Bladder
Study Phase
Phase 3
Study Completion Date
2007
NCT00445601Uploaded 01-08-2020
Access via NCI by Request
PDS UID: nci-data-397
N/A
Provider Information
Provider Data DescriptionThis dataset will allow users to reproduce the toxicity results reported in the Journal of American Medical Association (Messing et al., JAMA, 2018, PMID referenced above) for trial NCT00445601.
SponsorSouthwest Oncology Group
Data ProviderNational Cancer Institute
Clinical Trials.gov Information
Brief SummaryN/A
ConditionsN/A
Intervention TypeN/A
Drug(s)N/A
Total EnrolledN/A
RandomizationN/A
Blinding MethodN/A
Arms InterventionN/A
Secondary IDN/A
PubMed (PMID)N/A
Collaborator(s)N/A
Region(s)N/A
Age RangeN/A
Files: NCT00445601-D2
Data DictionaryNCT00445601-D2-Data-Dictionary_2.pdf
DATANCT00445601-D2-Dataset_2.csv
OTHERREADME.pdf
Files: NCT00445601-D1
Data DictionaryNCT00445601-D1-Data-Dictionary_3.pdf
DATANCT00445601-D1-Dataset_3.csv
OTHERREADME.pdf
© 2023 Project Data Sphere
All rights reserved
Privacy PolicyTerms of Use